Differential expression profile of miRNAs in amniotic fluid exosomes from fetuses with Down syndrome.
10.12122/j.issn.1673-4254.2022.02.18
- Author:
Kai Ze DING
1
;
Lei YU
2
;
Zhi HUANG
3
;
Hui Ling ZHENG
3
;
Xue YANG
3
;
Tian TIAN
3
;
Ru Jia XIE
1
Author Information
1. Department of Pathophysiology, Guizhou Medical University, Guiyang 550025, China.
2. Department of Pathology, Guiyang Maternal and Child Health Care Center, Guiyang 550003, China.
3. Department of Eugenic Genetics, Guiyang Maternal and Child Health Care Center, Guiyang 550003, China.
- Publication Type:Journal Article
- Keywords:
Down syndrome;
amniotic fluid;
exosomes;
miRNA
- MeSH:
Amniotic Fluid/metabolism*;
Down Syndrome/genetics*;
Exosomes;
Female;
Humans;
MicroRNAs/metabolism*;
Pregnancy
- From:
Journal of Southern Medical University
2022;42(2):293-299
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the role of miRNAs in amniotic fluid exosomes in growth and development of fetuses with Down syndrome (DS).
METHODS:Amniotic fluid were collected from 20 fetuses with DS and 20 normal fetuses (control) to extract amniotic exosome miRNA. MicroRNA sequencing technique was used to identify the differentially expressed miRNAs between the two groups, for which gene ontology (GO) and pathway analysis was performed. Three differentially expressed miRNAs with the strongest correlation with DS phenotype were selected for qPCR verification. Dual luciferase reporter assay was used to verify the activity of let-7d-5p for targeted regulation of BACH1.
RESULTS:We identified 15 differentially expressed miRNAs in DS as compared with the control group, among which 7 miRNAs were up-regulated and 8 were down-regulated. Target gene prediction results showed that the differentially expressed miRNAs targeted 17 DS-related genes. GO analysis revealed that the main functions of the target genes involved protein binding, protein transport, ATP binding, transferase activity and synapses. Pathway analysis revealed that the functional pathways were closely related with the development of the nervous system. qPCR results showed that the expression levels of miR-140-3p and let-7d-5p were significantly lower in DS group than in the control group (P < 0.05), as was consistent with miRNA sequencing results; the expression level of miR-4512 was significantly higher in DS group than in control group (P < 0.05), which was contrary to miRNA sequencing results. The results of double luciferase reporter gene assay confirmed that let-7d-5p was capable of targeted regulation of BACH1 expression.
CONCLUSION:Let-7d-5p in amniotic fluid exosomes may promote oxidative stress events in the brain of fetuses with DS by regulating BACH1 expression.
